Monday, Nov 03rd
Last update09:24:44 AM GMT
Health Glance
There is renewed controversy surrounding influenza vaccines, with some studies showing people immunised against the seasonal flu might have been at greater risk during the swine flu outbreak.
Infectious diseases expert Professor Peter Collignon has called for a review of Australia's flu vaccine policy in light of the new research, but the Federal Government has defended its vaccination program.
Shawn Clusky has seen every side of Kentucky's battle with pain pill addiction over the past 10 years. Clusky first tried OxyContin at age 17 with his school buddies, shortly after the high-powered narcotic painkiller went on the market. He was an occasional user and seller until about age 21, when he became fully addicted.
When he was 25, he got arrested at a Lexington gas station for selling $15,000 worth of pills. Clusky received probation, but was still using until he was sent to the WestCare rehabilitation center in eastern Kentucky. He now works there as a counselor.
The Swine Flu ‘pandemic’ turned out to be nothing more than a storm in a teacup generated by a flurry of conflicts of interest.
A majority of European Health Committee MEPs have nonetheless recently approved a report by Anne Delvaux (PPE) endorsing the existence of what was really an imaginary panic and calling for ‘more cooperation between member states’ to deal with future pandemics.
Are you drinking a cup of coffee right now? Congratulations, you may be lowering your risk of stroke, according to study of nearly 35,000 women published Thursday in Stroke: Journal of the American Heart Association.
The study led by Susanna Larsson of the Karolinska Institute in Stockholm followed women aged 49 to 83 for an average of 10 years, and found that those who drank more than one cup of coffee a day had a 22% to 25% lowered risk of stroke, compared with women who drank less. Further, the study found, drinking little or no coffee was actually associated with a slight increase in stroke risk.
The first new treatment for lupus in a half-century won U.S. approval on Wednesday, a milestone for patients with the disabling disease and a potential blockbuster for its tiny biotech maker.
Health officials cleared Benlysta, discovered by Human Genome Sciences Inc, to combat the disease that causes the immune system to attack joints and organs and has proved tough to study and treat.
Context The dramatic increase in use of cellular telephones has generated concern about possible negative effects of radiofrequency signals delivered to the brain. However, whether acute cell phone exposure affects the human brain is unclear.
Objective To evaluate if acute cell phone exposure affects brain glucose metabolism, a marker of brain activity.
On top of criticism that the U.S. Food and Drug Administration approves medical devices with too little oversight comes another troubling finding: Many heart-related devices win FDA approval without being adequately tested on women, despite an agency directive to do so.
This means that heart valves, pacemakers, defibrillators and stents get implanted in women without evidence that they benefit this population, researchers from the University of California, San Francisco say.
Page 113 of 232
